|
Patrick J. McEnany is a founder and Chief Executive Officer of Catalyst Pharmaceutical Partners, a drug development company formed in January 2002. From 1991 to April of 1997, Mr. McEnany was Chairman and President of Royce Laboratories, Inc., a Miami, Florida- based manufacturer of generic prescription drugs. Following the merger of Royce into Watson Pharmaceuticals, Inc., Mr. McEnany served (1997-1998) as President of the wholly-owned Royce Laboratories subsidiary and Vice President of Corporate Development for Watson Pharmaceuticals, Inc. He was Vice Chairman and Director of the National Association of Pharmaceutical Manufacturers (1993-1997) and currently serves on the Board of Directors for Renal CarePartners, Inc., an operator of kidney dialysis centers, and the Jackson Memorial Hospital Foundation. Mr. McEnany sat on the Board of Directors of Med/Waste, Inc. His tenure was March 2000 to February 13, 2002, when the company filed for voluntary bankruptcy protection under federal bankruptcy laws. | 